nafronyl has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balashova, TS; Konstantinovskaia, TA; Kubatiev, AA; Smirnova, VIu; Strokov, IA | 1 |
| Khodabandehlou, T; Le Dévéhat, C; Mosnier, M | 1 |
2 other study(ies) available for nafronyl and Diabetic Angiopathies
| Article | Year |
|---|---|
[The effect of naftidrofuryl on peroxidation of serum and erythrocyte membrane lipids in patients with insulin-dependent diabetes mellitus].
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Erythrocyte Membrane; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Nafronyl; Serotonin Antagonists | 1996 |
Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
Topics: Aged; Aged, 80 and over; Aspirin; Diabetic Angiopathies; Drug Interactions; Female; Humans; Male; Middle Aged; Nafronyl; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 2000 |